Nestmann Pharma GmbH, headquartered in Zapfendorf, manufactures and sells pharmaceutical preparations and dietary supplements. In fiscal year 2023 the company employed on average 59 employees and reported a net loss (Jahresfehlbetrag) of EUR 66,106.42. Total assets amounted to EUR 9,312,354.24 and equity to EUR 8,263,200.21, corresponding to a reported equity ratio of 89%. Gross profit was EUR 3,720,461.70, the material cost ratio decreased to 24.78% (prior year 30.84%), and cash holdings amounted to EUR 2,119,307.37 (decrease -9.28%). Nestmann Pharma GmbH is a family business.
Die Herstellung und der Vertrieb von pharmazeutischen Präparaten sowie branchenähnlicher und zugehöriger Artikel
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Bamberg Local Court, HRB 4735 (as of 6 October 2026)
Source: German Commercial Register (Handelsregister) Bamberg Local Court, HRB 4735 (as of 6 October 2026)
Source: German Commercial Register (Handelsregister) Bamberg Local Court, HRB 4735 (as of 6 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Bamberg Local Court, HRB 4735 (as of 6 October 2026)
PAION Deutschland GmbH
Aachen · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Boehringer Ingelheim Animal Health International GmbH
Ingelheim am Rhein · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
PB Pharma GmbH
Meerbusch · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sign in to view detailed salary and cost trends.
